Since the soluble sodium phosphate form of riboflavin is unavailable, is it possible to compound a high-dose riboflavin suspension (preferably 400 mg/5 ml) for a migraine patient, ensuring it has an acceptable taste and sufficient stability (2–3 months) to avoid the need for biweekly visits?

How much sodium citrate should be prescribed to obtain 1 g of bicarbonate based on the corresponding conversion, given a daily dose of one capsule taken three times?

Given that Na-secobarbital has been used to prepare capsules for a patient for a long time but is currently unavailable as a raw material and only available as a base, should a change in bioavailability be taken into account?

Is a 10% concentration realistic for a prescription to prepare 20 units of a 20 ml sucralfate 10% enema, given that Micromedex suggests a preparation method using a 10% methylcellulose solution and 100 tablets of Ulcogant 1g?

Does the combination of zinc oxide and nystatine in a cream base influence the pH, and should the zinc oxide be replaced to accommodate the nystatine?

What is the cause of the pink discoloration observed after one day in a cream composed of 1 g promethazine, 2 g lidocaine HCl, 0.3 g menthol, and hydrocortisone acetate 1% cream TMF up to 50 g?

What is the appropriate concentration of hydroxyethylcellulose (HEC) for a gel containing 0.1% triamcinolone acetonide intended for application to the oral mucosa, given that the percentage of HEC is not specified but 6% is being considered?